Yüklüyor......
Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer
BACKGROUND: Localized rectal cancer responds well to 5-fluorouracil and radiation-based regimens. A phase I–II trial is currently testing the efficacy of adding bevacizumab, a VEGF-specific antibody, to standard chemoradiotherapy. The case presented here is a complete pathological response seen in a...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2007
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2686127/ https://ncbi.nlm.nih.gov/pubmed/17464339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncponc0813 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|